- US-listed companies
- STAAR SURGICAL CO
- Income statement
STAAR SURGICAL COSTAA
Market cap
$1.3B
P/E ratio
| 2011/12 | 2012/12 | 2014/01 | 2015/01 | 2016/01 | 2016/12 | 2017/12 | 2018/12 | 2020/01 | 2021/01 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 63 | 64 | 72 | 75 | 77 | 82 | 91 | 124 | 150 | 163 | 230 | 284 | 322 | 314 |
| Revenue growth (%) | - | - | - | |||||||||||
| Cost of revenue | 20 | 19 | 22 | 26 | 24 | 24 | 26 | 32 | 38 | 45 | 52 | 61 | 70 | 74 |
| Gross profit | 42 | 44 | 50 | 49 | 53 | 58 | 64 | 92 | 112 | 118 | 179 | 223 | 253 | 240 |
| Gross margin (%) | ||||||||||||||
| Research & development | 6 | 6 | 7 | 12 | 15 | 20 | 19 | 22 | 25 | 32 | 34 | 36 | 44 | 54 |
| Selling, general & administrative | - | - | - | - | - | - | - | 85 | 100 | 112 | 145 | 180 | 225 | 252 |
| Operating margin (%) | ||||||||||||||
| Operating income | 3 | -1 | 1 | -8 | -5 | -13 | -4 | 7 | 12 | 7 | 33 | 44 | 28 | -13 |
| Income before tax | 3 | -1 | 1 | -9 | -6 | -12 | -2 | 7 | 13 | 8 | 31 | 46 | 34 | -9 |
| Pretax margin (%) | 4.3 | -0.8 | 1.5 | -11.5 | -7.3 | -15.1 | -2.5 | 5.4 | 8.7 | 5.1 | 13.6 | 16 | 10.5 | -2.9 |
| Provision for income taxes | 1 | 1 | 1 | -0 | 1 | -0 | -0 | 2 | -1,022,000 | 2 | 7 | 7 | 12 | 11 |
| Effective tax rate (%) | ||||||||||||||
| Net income | 1 | -2 | 0 | -8 | -7 | -12 | -2 | 5 | 14 | 6 | 25 | 39 | 21 | -20 |
| Net income margin (%) | ||||||||||||||
| Earnings per share | 0.04 | -0.05 | 0.01 | -0.22 | -0.17 | - | - | 0.12 | 0.32 | 0.13 | 0.52 | 0.81 | 0.44 | -0.41 |
| Diluted EPS | 0.04 | -0.05 | 0.01 | -0.22 | -0.17 | - | - | 0.11 | 0.3 | 0.12 | 0.5 | 0.78 | 0.43 | -0.41 |